Nanox Partners with Olympe Imagerie for Enhanced Lung Cancer Detection
Olympe Imagerie will implement Nanox.ARC at a local hospital for lung cancer screening.
PETACH TIKVA, Israel – An innovative medical imaging company, Nanox (NASDAQ: NNOX), has announced a new collaboration with Olympe Imagerie, a Paris-focused group of independent radiologists, to deploy its advanced imaging technology, the Nanox.ARC, aimed at enhancing lung cancer screening capabilities.
Collaboration Goals and Implementation
The deployment of the Nanox.ARC system is set to occur at the Hospital Privé Jacques Cartier MASSY, showcasing Nanox's commitment to expanding their clinical research within France. This significant step marks progress in establishing a clinical presence in Europe and advancing research in the fight against lung cancer.
The pivotal clinical trials planned will effectively assess and validate the contributions of the Nanox.ARC in supporting lung cancer detection, management, and screening. It aims to improve diagnostic capabilities which could lead to better patient outcomes.
Technological Innovations of Nanox.ARC
The Nanox.ARC system provides a multi-source digital tomosynthesis, utilizing advanced 3D imaging technology to deliver superior diagnostics at reduced costs compared to conventional systems. Following its CE Mark certification, secured earlier this year, the Nanox.ARC is officially cleared for commercialization across the European Union, marking a significant achievement for the company.
This strategic collaboration plays a crucial role in reinforcing Nanox's clinical validation approach in France, further emphasizing their vision to enhance healthcare access throughout the region.
Key Insights from Company Leaders
Erez Meltzer, the CEO and Acting Chairman of Nanox, acknowledged the significance of France as a critical market for their expansion strategy. He stated, "Partnering with Olympe Imagerie and Hospital Privé Jacques Cartier MASSY helps position our technology favorably in clinical scenarios where the early detection of lung cancer can dramatically alter patient survival rates."
Additionally, Romain Pommier, an associate radiologist at Olympe Imagerie, expressed the importance of this collaboration, highlighting their commitment to evaluating advanced imaging solutions to enhance lung cancer diagnostics. He stated, "We're thrilled to be among the first in Europe to explore Nanox's state-of-the-art imaging technologies and how they can potentially transform our diagnostic practices and patient care standards."
About Nanox
Nanox (NASDAQ: NNOX) is dedicated to revolutionizing healthcare by making preventive health accessible through advanced medical imaging technologies. The company focuses on delivering a comprehensive solution utilizing artificial intelligence (AI) and proprietary digital X-ray sources to enhance diagnostic efficiencies and improve health outcomes.
The Nanox ecosystem includes various components like Nanox.AI, a robust suite of imaging algorithms designed to identify early signs of chronic diseases, and Nanox.CLOUD, a software platform for data management and imaging analysis.
Nanox aims to alter the landscape of medical imaging by developing a proactive system that seamlessly integrates imaging processes from patient scanning to diagnostic analysis, ultimately improving healthcare delivery worldwide.
Frequently Asked Questions
What is the purpose of the Nanox.ARC system?
The Nanox.ARC system is designed for lung cancer detection and management, utilizing advanced 3D imaging technology to enhance diagnostic capacity.
Where is the Nanox.ARC system being deployed?
It will be deployed at the Hospital Privé Jacques Cartier MASSY in France.
Who is Nanox collaborating with?
Nanox is collaborating with Olympe Imagerie, a group of independent radiologists based in Paris.
What does Nanox aim to achieve with this collaboration?
Nanox aims to establish clinical validation for their imaging technology and enhance lung cancer screening capabilities within Europe.
What is Nanox's vision for the future of healthcare?
Nanox envisions transforming the healthcare landscape through accessible preventive care facilitated by advanced imaging technologies and AI integration.
